ReviewJournal of hepatocellular carcinoma2025
A Patient Charter to Improve Care for Hepatocellular Carcinoma.
Review in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma.Medical sciences (Basel, Switzerland) · 2026Article
- Factors associated with unmet psychological care needs and development of a Neuman systems model-based risk prediction model in patients with hepatocellular carcinoma.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To establish a patient charter that articulates the principles of quality care for individuals living with hepatocellular carcinoma (HCC), aiming to improve patient outcomes and survival rates globally. Methods: A multidisciplinary group comprising healthcare professionals, patient advocacy representatives, and policymakers convened to identify the critical areas of unmet need in HCC care. The group shared patient experiences, barriers, and insights - particularly with input from Patient Advocacy Groups (PAGs) - to better understand the challenges faced by patients. They reviewed existing literature, current care practices, and patient experiences to formulate a patient charter that outlines the principles of quality care for HCC. Results: The patient charter identifies the seven principles of quality care that people with HCC or at risk of developing HCC should expect to receive in order to benefit from improved outcomes and increased survival. These principles address the need for policy prioritization, early diagnosis, multidisciplinary care, personalized treatment, shared decision-making, stigma-free access to services and increased research funding. Conclusion: The patient charter serves as a call to action for stakeholders to unite in enhancing the care and treatment of HCC, with the ultimate goal of improving health outcomes for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.